IT1274351B - Uso di alcuni glicosaminoglicani nella dialisi peritoneale. - Google Patents

Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Info

Publication number
IT1274351B
IT1274351B ITBO940436A ITBO940436A IT1274351B IT 1274351 B IT1274351 B IT 1274351B IT BO940436 A ITBO940436 A IT BO940436A IT BO940436 A ITBO940436 A IT BO940436A IT 1274351 B IT1274351 B IT 1274351B
Authority
IT
Italy
Prior art keywords
peritoneal
sulodexide
subjected
molecular weight
low molecular
Prior art date
Application number
ITBO940436A
Other languages
English (en)
Inventor
Bruno Baggio
Giorgio Bazzato
Agostino Fracasso
Giovanni Gambaro
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO940436A0 publication Critical patent/ITBO940436A0/it
Priority to ITBO940436A priority Critical patent/IT1274351B/it
Priority to ES95113868T priority patent/ES2157277T3/es
Priority to EP95113868A priority patent/EP0710483B1/en
Priority to DE69521388T priority patent/DE69521388T2/de
Priority to DK95113868T priority patent/DK0710483T3/da
Priority to AT95113868T priority patent/ATE202282T1/de
Priority to PT95113868T priority patent/PT710483E/pt
Priority to US08/530,597 priority patent/US5686432A/en
Publication of ITBO940436A1 publication Critical patent/ITBO940436A1/it
Application granted granted Critical
Publication of IT1274351B publication Critical patent/IT1274351B/it
Priority to GR20010401009T priority patent/GR3036158T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITBO940436A 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale. IT1274351B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
DK95113868T DK0710483T3 (da) 1994-10-06 1995-09-04 Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt
EP95113868A EP0710483B1 (en) 1994-10-06 1995-09-04 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure
DE69521388T DE69521388T2 (de) 1994-10-06 1995-09-04 Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens
ES95113868T ES2157277T3 (es) 1994-10-06 1995-09-04 Uso de glucosaminoglucanos para la fabricacion de un medicamento para el tratamiento de insuficiencia renal cronica.
AT95113868T ATE202282T1 (de) 1994-10-06 1995-09-04 Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagens
PT95113868T PT710483E (pt) 1994-10-06 1995-09-04 Utilizacao de alguns glicosaminoglicanos para a producao de um medicamento para o tratamento da insuficiencia renal cronica
US08/530,597 US5686432A (en) 1994-10-06 1995-09-19 Use of some glycosaminoglycans in the peritoneal dialysis
GR20010401009T GR3036158T3 (en) 1994-10-06 2001-06-29 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Publications (3)

Publication Number Publication Date
ITBO940436A0 ITBO940436A0 (it) 1994-10-06
ITBO940436A1 ITBO940436A1 (it) 1996-04-06
IT1274351B true IT1274351B (it) 1997-07-17

Family

ID=11340040

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Country Status (9)

Country Link
US (1) US5686432A (it)
EP (1) EP0710483B1 (it)
AT (1) ATE202282T1 (it)
DE (1) DE69521388T2 (it)
DK (1) DK0710483T3 (it)
ES (1) ES2157277T3 (it)
GR (1) GR3036158T3 (it)
IT (1) IT1274351B (it)
PT (1) PT710483E (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
JP2003504428A (ja) * 1999-06-30 2003-02-04 ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド クロット関連凝固因子を阻害するヘパリン組成物
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
US7259152B2 (en) * 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
US20030013680A1 (en) * 2001-06-12 2003-01-16 Keryx Methods using glycosaminoglycans for the treatment of nephropathy
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
EP1890686B1 (en) 2005-05-30 2017-10-04 Fresenius Medical Care Deutschland GmbH Peritoneal dialysis fluid
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
WO2009044765A1 (ja) * 2007-10-01 2009-04-09 Seikagaku Corporation 新規な低分子化コンドロイチン硫酸およびその用途
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
IT1401253B1 (it) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
DE69429576T2 (de) * 1993-09-30 2002-08-22 Seikagaku Kogyo K.K., Tokio/Tokyo Dermatansulfatezusammensetzung als antithromotisches mittel

Also Published As

Publication number Publication date
PT710483E (pt) 2001-09-28
ITBO940436A1 (it) 1996-04-06
ITBO940436A0 (it) 1994-10-06
EP0710483B1 (en) 2001-06-20
US5686432A (en) 1997-11-11
DK0710483T3 (da) 2001-09-03
ATE202282T1 (de) 2001-07-15
DE69521388D1 (de) 2001-07-26
DE69521388T2 (de) 2001-10-11
EP0710483A1 (en) 1996-05-08
ES2157277T3 (es) 2001-08-16
GR3036158T3 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
GR3036158T3 (en) Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure
Taylor et al. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients
Amyot et al. Myoglobin clearance and removal during continuous venovenous hemofiltration
Mistry et al. Kinetic and Clinical Studies of β2Microglobulin in Continuous Ambulatory Peritoneal Dialysis: Influence of Renal and Enhanced Peritoneal Clearances Using Glucose Polymer
von Lilien et al. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children
Odlind et al. Diuretic resistance: reduced bioavailability and effect of oral frusemide
Bunchman et al. Treatment of vancomycin overdose using high-efficiency dialysis membranes
Gross et al. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis
Koup et al. Ceftriaxone pharmacokinetics during peritoneal dialysis
Wise et al. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction
Kaplan et al. Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome
Nensel et al. Dialyzer permeability for low-molecular-weight proteins: comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers
Schrader et al. Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis
Kessler et al. Dialysis pruritus and sensitization
Pahl et al. In-vivo and in-vitro hemodialysis studies of thiocyanate
Gotloib et al. Hemofiltration in severe septic adult respiratory distress syndrome associated with varicella
Bergstrom Serum middle molecules and continuous ambulatory peritoneal dialysis
Coelho et al. Extracorporeal light chains removal–What role does this play in 2020?
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
Von Herrath et al. Good biocompatibility of the polyamide hemofilter
Sieberth Continuous Extracorporeal Treatment in Multiple Organ Dysfunction Syndrome: 3rd International Conference on Continuous Hemofiltration, Vienna, July 1994
Albertioni et al. Protein binding of 2-chloro 2′-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemia
RU96113786A (ru) Антикоагулянтное средство
Barth Pros and cons of short, high efficiency, and high flux dialysis
Leichter et al. The optimal dialysis regimen for children Undergoing different continuous cycling peritoneal dialysis protocols

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970716